Previous issues
- Page Path
-
- HOME
- BROWSE ARTICLES
- Previous issue
|
- Reviews
- The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
- Hae Lim Lee, Sung Won Lee
- Clin Mol Hepatol. 2022;28(2):121-134. Published online September 27, 2021
- Approaches to quantifying hepatitis B virus covalently closed circular DNA
- Henrik Zhang, Thomas Tu
- Clin Mol Hepatol. 2022;28(2):135-149. Published online October 22, 2021
- MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
- Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):150-163. Published online November 10, 2021
- Cost-effectiveness of chronic hepatitis C screening and treatment
- Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim
- Clin Mol Hepatol. 2022;28(2):164-173. Published online December 27, 2021
- Editorials
- Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
- Bo Hyun Kim
- Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022
- Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
- Takumi Kawaguchi, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):177-180. Published online August 26, 2021
- Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
- Hung-Yao Lin, Tai-Chung Tseng
- Clin Mol Hepatol. 2022;28(2):181-182. Published online February 21, 2022
- Original Articles
- Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
- Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng
- Clin Mol Hepatol. 2022;28(2):183-195. Published online November 28, 2021
- Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
- Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
- Clin Mol Hepatol. 2022;28(2):196-206. Published online January 13, 2022
- Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
- Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
- Clin Mol Hepatol. 2022;28(2):207-218. Published online November 24, 2021
- Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
- Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song
- Clin Mol Hepatol. 2022;28(2):219-231. Published online July 20, 2021
- Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats
- Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee
- Clin Mol Hepatol. 2022;28(2):232-241. Published online January 5, 2022
- Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area
- Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho
- Clin Mol Hepatol. 2022;28(2):242-253. Published online February 7, 2022
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
- Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park
- Clin Mol Hepatol. 2022;28(2):254-264. Published online December 28, 2021
- Letters to the Editor
- Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei
- Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022
- Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Jihyun An, Ju Hyun Shim
- Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022
- Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
- Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022
- Snapshot
- Acute on chronic liver failure in cirrhosis
- Marta Tonon, Salvatore Piano
- Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022
- Guideline
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor8.9First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
